All SEC Filings :: Navidea Biopharmaceuticals, Inc. (NAVB)

Filing Type:

Year:

Date	Form	Description	Pages
03/14/97	8-K	Current report filing Documents EX-23.1 EX-27 EX-99.1	25
03/14/97	S-3/A	Registration statement for specified transactions by certain issuers Documents EX-23	23
02/28/97	424B3	Prospectus filed pursuant to Rule 424(b)(3)	16
02/28/97	10QSB/A	Optional form for quarterly and transition reports of small business issuers Documents EX-11.1 EX-27	16
02/12/97	SC 13G	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Documents EX-21 EX-99.1	7
02/04/97	S-8	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Documents EX-5.1 EX-23.1 EX-24.1 EX-24.2	17
12/23/96	8-A12G/A	Form for registration of a class of securities pursuant to Section 12(g)	2
12/23/96	15-12G	Notice of termination of registration of a class of securities under Section 12(g)	1
12/10/96	8-A12G/A	Form for registration of a class of securities pursuant to Section 12(g)	5
12/10/96	POS AM	Post-effective amendment to a registration statement that is not immediately effective upon filing	3